A progress in neuroimaging research on the central mechanisms of botulinum toxin in the treatment of focal dystonia
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 7
Abstract
Botulinum toxin (BoNT) is currently the first-line method for treating focal dystonia, which causes muscle paralysis by chemical denervation. Recent neuroimaging studies have found that BoNT treatment could alter neuroplasticity in the brain of patients with focal dystonia. However, the specific central nervous system mechanisms have not been fully elucidated. To this end, here we review the neuroimaging studies on BoNT treatment for dystonia from three aspects: functional magnetic resonance imaging, structural magnetic resonance imaging, and positron emission tomography imaging. It suggests that BoNT may improve the symptoms of dystonia patients by affecting functional connectivity, microstructure, and metabolic levels of the cortex, basal ganglia, thalamus, and cerebellum, etc. Therefore, this review will provide a theoretical reference for further exploring the mechanism and developing potential therapeutic targets of dystonia.
Authors and Affiliations
Qinying MU, Junhao HU, Fuhao MA, Hao WANG, Weikang DOU, Liyi CHI, Ming. SHI
Keywords
Related Articles
- EP ID EP750521
- DOI 10.3969/j.issn.1002-0152.2024.07.008
- Views 32
- Downloads 0
Incidence and predictors of early radial artery occlusion associated transradial approach
ObjectiveThis study was to explore factors related to early radial artery occlusion (RAO) associated transradial approach(TRA).MethodsPatients who underwent the TRA from July 2021 to Jan 2024 were included in our study....
A case report of Parkinson disease complicated with myasthenia gravis
This case report described an 80-year-old male patient with Parkinson disease (PD) complicated with myasthenia gravis (MG). Six years ago,the patient was diagnosed with PD based on the motor symptoms including bradykines...
Molecular basis underlying gray matter volume changes in patients with AIWG: a transcriptome-neuroimaging study
[Objective] To investigate the gray matter volume (GMV) changes and molecular basis underlying antipsychotic-induced weight gain (AIWG). [Methods] One hundred twenty-nine first-episode schizophrenia patients from October...
a case of paraneoplastic cerebellar ataxia syndrome associated with immunocheckpoint inhibitor treated with Ofatumumab
A case of paraneoplastic cerebellar ataxia syndrome caused by immune checkpoint inhibitors (ICI) was treated with ofatumumab (OFA). The patient is a 57-year-old male. He used “Camrelizumab” immunotherapy for his previous...
Research progress on ALSP caused by CSF1R gene mutations
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a clinically rare autosomal dominant genetic disease, and its specific pathogenesis is not yet clear. The colony-stimulating factor 1 rec...